Ask a Fool: Gilead Sciences on a Downward Trend -- Should I Hold Firm?

In this video as part of The Motley Fool's "Ask a Fool" series, Fool health-care analyst David Williamson takes a question from a Fool reader, who asks, "Gilead Sciences (NASDAQ: GILD  ) seems to be on a down trend. Is there any specific reason, or should I just hold firm?"

David takes a look at Gilead's downward trend year to date but cautions that this 3% pullback since the beginning of 2014 is much better understood in the context of the stock's meteoric rise over the past 12 months. He then discusses for investors the company's hepatitis C drug Sofosbuvir, sold under the name Sovaldi, and how much of the investing thesis is based around the success of this drug. He notes that while the drug is destined to be a blockbuster with an incredible cure rate, it has its risks that investors need to be aware of. Finally, David looks at Gilead's pipeline, and the future of the company.

What's the best buy in biotech today?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that Big Pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2795346, ~/Articles/ArticleHandler.aspx, 12/18/2014 12:34:26 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement